Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
20.5M
-
Shares change
-
+2.33M
-
Total reported value, excl. options
-
$804M
-
Value change
-
+$94M
-
Number of buys
-
46
-
Number of sells
-
-26
-
Price
-
$39.15
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q1 2014
79 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2014.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.5M shares
of 58.6M outstanding shares and own 35.04% of the company stock.
Largest 10 shareholders include Third Rock Ventures, LLC (5.56M shares), Flagship Ventures 2007 General Partner LLC (3.86M shares), FMR LLC (3.64M shares), WELLINGTON MANAGEMENT CO LLP (1.11M shares), VANGUARD GROUP INC (754K shares), BlackRock Fund Advisors (550K shares), FRANKLIN RESOURCES INC (478K shares), EVENTIDE ASSET MANAGEMENT, LLC (454K shares), LORD, ABBETT & CO. LLC (435K shares), and Capital World Investors (335K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.